Every cancer type involves specific treatment procedures, surgeries, radiotherapy, and chemotherapy. But these treatments may cause side effects and
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problems affecting healthy tissues or organs. These side effects include anemia, loss of appetite, bleeding, edema, fatigue, hair loss, infection and memory or concentration problems hence affecting overall 6,7 quality of life (QOL) of patients. Various complementary and alternative methods (CAM) are used especially traditional medicinal plants have been 8 used to treat various ailments and serious diseases. Medicinal plants contain bioactive compounds that play vital role being structural and functional parts of enzymes, proteins and hormones. Scientists and nutritionists have been using plant extracts to cure and improve human life style. Plant based secondary metabolites such as tannins, terpenoid, flavonoids and alkaloids possess a lot of potential to be used for 9 possible curative and medicinal use.
Pakistan has a rich and prestigious heritage of medicinal plants. However The purpose of this research work was to explore the cytotoxic effects of these medicinal plants and to compare them with natural plant based Terpenes, so that they can be isolated, characterized and used as potential anticancer drugs in future.
Methods
The experimental study is based on the comparative evaluation of cytotoxic potential of medicinal plants of Pakistan, plant Terpenes and standard medicine. washed properly, shade dried at room temperature (20°C-30°C) and pulverized into fine powder for the further use.
Sample powdered material of all selected plants was extracted with ethanol by maceration for successive 3 days. 2.0 g of each sample was extracted and 50 mL of ethanol was added with gentle stirring for 72 h. The extracts were filtered, collected in glass vials and were concentrated by using a rotary evaporator.
Standard methods of phytochemical analyses were performed to detect the phyto-constituents, viz. terpenoids, flavonoids, alkaloids, phenolics and Normal mouse fibroblast cells (NIH/3T3, ATCC #: CRL-1658 (lot. No. 59049195) were used for in vitro cytotoxic comparison of plant extracts. Cell lines was cultured in advanced Dulbecco's Modified Eagle Medium (DMEM) augmented with 10% inactivated NBCS (newborn calf serum) and 5mM l-glutamine, and maintained at 37°C in a humidified atmosphere of 5% CO in air. 2 Cytotoxic activity of ethanolic extracts as well as selected three plant terpenes (Methyl decanoate, Hexadecanoic acid, methyl ester, n-Hexadecanoic acid) were assessed in 96-well format substrate for high throughput screening (HTS) by MTT colori- (18) metric assay . Mouse fibroblasts (3T3) cells were cultured in DMEM medium containing 5% FBS (fetal bovine serum), penicillin (100 IU/mL) and 2 streptomycin (100 µg/mL). The flasks 75 cm were incubated in 5% CO incubator at 37°C. Repeatedly 2 growing cells were picked carefully under aseptic condition and counted by haemocytometer. Cellular concentration (5×104cells/mL) was prepared and poured into 96-well plate and left for overnight. Medium was removed after overnight incubation and 200 µL of fresh medium added along with different concentrations (1-30µM). After 48 hours MTT substrate was prepared (0.5 mg/mL) in a physiologically balanced solution, 200 µL was added into the medium and placed in incubator for further 4 hours. Afterwards, 100µL of DMSO was mixed to each well. Viable cells with active metabolism reduced MTT to formazan product (purple colour), that was monitored and calculated by absorbance at 540 nm using a Micro Plate Reader (Spectra Max plus, Molecular Devices, CA, USA). Extracts showing cytotoxic activity were further tested and calculated the IC50 values. IC50 of the compound for the cytotoxicity noted at concentration caused 50% cellular inhibition of 3T3 cells. The results were analyzed by using Soft-Max Pro software (Molecular Device, USA). Each experiment was performed in triplicate. The IC50 values were calculated with Probit analysis software (LdP Line software, USA).
Results
Qualitative phytochemical analysis of fruit/seed extracts indicated terpenoids, flavonoids, phenols, quinine, saponins, glycosides and alkaloids. The results of our previous study revealed that these plants 16 had high terpenoid contents, In another study, we purposed that these terpenoid contents may be the major contributing factors for the highest antioxidant potential of the fruit extracts by DPPH free radical Tables 1 &  2) . The results showed that all plant extracts were found to beless toxic against 3T3 cell lines as compared to n-Hexadecanoic acid and cyclohexamide. Whereas the selected terpenes; methyl decanoate exhibited 11%, Hexadecanoic acid, methyl ester (16%) were also inactive against cellular activity except n Hexadecanoic acid (88%), and standard cyclohexamide 70% were found to be toxic against 3T3 cell line with IC50 (cyclohexamide 0.8±0.2). 
Figure 1: Cytotoxic inhibition of Ethanolic Extracts of Plants in Comparison with Cyclohexamide Against Normal Mouse Fibroblasts (NIH 3T3).

Figure 2: Cytotoxic Inhibition of Identified Plant Terpenes in Comparison with Cyclohexamide Against Normal Mouse Fibroblasts (NIH 3T3).
Discussion
Pakistan being an agricultural land is a precious source of medicinal and ornamental plants. The overall environment, humidity level, and several other contributing factors affect overall medicinal 17 and pharmacological properties of the plants. Local herbalists use these medicinal plants to cure local
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infectious problems.
A big population of Pakistan can't afford costly anticancer synthetic medicines, therefore, they have to import them. If we are successful to use these plants as anticancer, then this will not only decrease the burden on economy of Pakistan but also provide local medication that can be more effective for the local people because of their same environment. Moreover, these medicines will have low side effects, cost effective, easily available help to improve quality of life of patients.
Our study describes cytotoxic investigations of 25 medicinal plants so far not studied and screened for cytotoxic activity against healthy mouse fibroblasts by using MTT assay. All these plant extracts were found to be inactive against 3T3 cells and exhibited various range of inhibition. The fruit/seed extracts of C. speciosa (3%), D. malabarica (8%), J. mimosifolia (11%), C. absus (13%), C. paniculatus (13%), F.arabica (16%), B. lanzan (21%), M. incana (24%), E. cheiri (26%), H.adenophyllum (38%), Z.tenuior (39%), T.patula (39%) and C.verum (45%) were inactive, and methyl decanoate (11%), methyl palmitate (16%) was almost nontoxic. All these plants extracts can be used safely in the cancer treatment without exerting damage to normal healthy cells.
In this study, for the first time we have compared the cytotoxic activity of our selected plants with natural terpenes. In our previous study, we have investigated Hence, we can say that these Terpenoids may be acting as shield for normal healthy fibroblasts cells and found to be inactive against them as compared to the cancerous cells. Now, our further plans will be the use of isolation and standardization of potent Terpenoids from these medicinal plants and use them against cancer cell lines. If we are successful in doing this, it will bring a revolution in cancer treatment with minimum side effects and low cost. Moreover, local medicine may lead to personalized medicine in future too. We also welcome the researchers, pharmacists, healthcare professionals and drug analysts for future experimentation, leading to natural compounds purification, in vitro anticancer activity, in vivo administration (animal models) before clinical trials of these medicinal plants. In this way, they may help towards the anticancer drug development after investigating in vitro and in vivo administration and finally on clinical trials leading to drug standardization.
Conclusion
This study confirms that the selected medicinal plants are rich in anticancer, chemo-preventive and medicinally important Terpenoids and proved to be inactive against healthy mouse fibroblasts (NIH 3T3) cells. Whereas, the further steps requiring anticancer potential and preclinical trials on cancer animal model will be vital steps to use them on commercial scales in future.
